Skip to content

A Study for evaluating the effectiveness of nutrition therapy in patients with cirrhosis with impaired glucose tolerance using continuous glucose monitoring and body composition analyzer

A Study for evaluating the effectiveness of nutrition therapy in patients with cirrhosis with impaired glucose tolerance using continuous glucose monitoring and body composition analyzer - A Study for evaluating the effectiveness of nutrition therapy in patients with cirrhosis with impaired glucose tolerance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035952
Enrollment
250
Registered
2019-03-01
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis with impaired glucose tolerance

Interventions

To evaluate the continuous blood glucose level in the cirrhotic patient with impaired glucose tolerance before and after 2 weeks of the nutrition therapy.

Sponsors

Hamamatsu University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 20 years or older 2 Have a histologically or clinically confirmed diagnosis of liver cirrhosis 3 Have impaired glucose tolerance 4 Informed and consent 5 Considered as a adaptation by the principal investigator

Exclusion criteria

Exclusion criteria: 1 Pacemaker 2 Another glucose monitoring 3 Pregnant 4 Cancer 5 Tendency to hemorrhages 6 Considered as a impropriety by the principal investigator 7 Withdraw the consent

Design outcomes

Primary

MeasureTime frame
To assess the changes of blood glucose level by nutrition therapy in cirrhotic patients with impaired glucose tolerance.

Countries

Japan

Contacts

Public ContactHidenao Noritake

Hamamatsu University School of Medicine Second department of internal medicine

noritake@hama-med.ac.jp053-435-2262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026